October 24th
19.00 - 20.30 PM CET
Novotel Campo de las Naciones • Madrid, Spain
WHERE AI MEETS CLINICAL DECISIONS
Join leading oncology experts to explore how artificial intelligence is transforming clinical trials, decision-making, and patient outcomes.
From real-world data to ethical challenges, this session will provide actionable insights into the future of oncology practice.
AGENDA
19:00 - 20:30
-
Welcome & Introduction
-
AI for Faster, Smarter Oncology Trials
Dr Enrique Grande + Discussion
-
AI, Real-World Data & Evidence
Dr Miriam Koopman + Discussion
-
AI for Clinical Decision Making & Biomarkers
Dr Loic Verlingue + Discussion
-
AI: Ethics, Disparities & Equity
Dr Jonathan Lim + Discussion
-
Q&A and Closing
*Includes access to ​MEDConnect corporate ​event (20:30 - Midnight)
SPEAKERS
.png)
WHAT TO EXPECT?
You will gain practical insights into how AI is transforming real-world oncology
-
Understand how AI is reshaping clinical decision-making in oncology
-
Hear directly from leading European experts at the forefront of innovation
-
Explore real-world applications, data, and case-driven insights
-
Address key challenges including ethics, bias, and implementation
-
Connect with peers across oncology, research, and innovation
LOCATION
Sponsors
This event is supported by industry partners committed to advancing oncology innovation.
About MEDSIR
A new model for collaborative research in clinical oncology
MEDSIR has more than a decade of experience developing strategic clinical trials in oncology, by combining the medical knowledge of our KOLs network, with a multidisciplinary expertise in clinical trials. Our innovative strategies lead to the generation of groundbreaking collaborative trials that respond to unmet clinical need while complementing the internal development program of your drug.
​
"
WE WANT TO IMPROVE THE LIVES OF CANCER PATIENTS BY ENSURING THEY HAVE ACCESS TO THE BEST TREATMENT OPTIONS FOR THEIR DISEASE.
